Abstract
The systematic use of evidence to inform healthcare decisions,
particularly health technology assessment (HTA), has gained
increased recognition. HTA has become a standard policy tool for
informing decision makers who must manage the entry and use of
pharmaceuticals, medical devices, and other technologies (including
complex interventions) within health systems, for example, through
reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize
good practices or emerging good practices to support populationbased decision-making in recent years. After the identification of
some good practices through the release of the ISPOR Guidelines
Index in 2013, the ISPOR HTA Council identified a need to more
thoroughly review existing guidance. The purpose of this effort was to
create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings
suggest that although many good practices have been developed in
areas of assessment and some other key aspects of defining HTA
processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the
impact of HTA. The extent to which these good practices are used and
applied by HTA bodies is beyond the scope of this report, but may be
of interest to future researchers.
particularly health technology assessment (HTA), has gained
increased recognition. HTA has become a standard policy tool for
informing decision makers who must manage the entry and use of
pharmaceuticals, medical devices, and other technologies (including
complex interventions) within health systems, for example, through
reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize
good practices or emerging good practices to support populationbased decision-making in recent years. After the identification of
some good practices through the release of the ISPOR Guidelines
Index in 2013, the ISPOR HTA Council identified a need to more
thoroughly review existing guidance. The purpose of this effort was to
create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings
suggest that although many good practices have been developed in
areas of assessment and some other key aspects of defining HTA
processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the
impact of HTA. The extent to which these good practices are used and
applied by HTA bodies is beyond the scope of this report, but may be
of interest to future researchers.
| Original language | English |
|---|---|
| Pages (from-to) | 13-20 |
| Number of pages | 8 |
| Journal | Value in Health |
| Volume | 22 |
| Issue number | 1 |
| Early online date | 13 Dec 2018 |
| DOIs | |
| Publication status | Published - Jan 2019 |